Stress-induced potentiation of cocaine reward: A role for CRF R1 and CREB

Neuropsychopharmacology

Volumn 34, Issue 12, 2009, Pages 2609-2617

  Kreibich, Arati S ^a   Briand, Lisa ^a   Cleck, Jessica N ^a   Ecke, Laurel ^a   Rice, Kenner C ^b   Blendy, Julie A ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c Translational Research Laboratories   (United States)

Author keywords

Cocaine; CPP; CREB; CRFR1; Forced swim stress

Indexed keywords

ANTALARMIN; COCAINE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG USE; FORCED SWIMMING TEST; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RECEPTOR BINDING; REWARD; STRESS;

ANIMALS; COCAINE; CONDITIONING, CLASSICAL; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOPAMINE UPTAKE INHIBITORS; MICE; MICE, KNOCKOUT; NUCLEUS ACCUMBENS; PHOSPHORYLATION; PYRIMIDINES; PYRROLES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REWARD; SEPTUM OF BRAIN; SPACE PERCEPTION; STRESS, PSYCHOLOGICAL; SWIMMING; TIME FACTORS;

EID: 70350044862     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.91     Document Type: Article

References (60)

1. Barrot M, Olivier JD, Perrotti LI, DiLeone RJ, Berton O, Eisch AJ et al (2002). CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci USA 99: 11435-11440.
2. Brown EE, Robertson GS, Fibiger HC (1992). Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures. J Neurosci 12: 4112-4121.
3. Carlezon Jr WA, Thomas MJ (2009). Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 56(Suppl 1): 122-132.
4. Carlezon Jr WA, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N et al (1998). Regulation of cocaine reward by CREB. Science (New York, NY) 282: 2272-2275.
5. Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA (2002). cAMP response element-binding protein is essential for the upregula-tion of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 22: 3262-3268.
6. Cooper JC, Knutson B (2008). Valence and salience contribute to nucleus accumbens activation. NeuroImage 39: 538-547.
7. Dayas CV, Buller KM, Crane JW, Xu Y, Day TA (2001). Stressor categorization: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups. Eur J Neurosci 14: 1143-1152.
8. Der-Avakian A, Bland ST, Rozeske RR, Tamblyn JP, Hutchinson MR, Watkins LR et al (2007). The effects of a single exposure to uncontrollable stress on the subsequent conditioned place preference responses to oxycodone, cocaine, and ethanol in rats. Psychopharmacology (Berl) 191: 909-917.
9. Der-Avakian A, Will MJ, Bland ST, Deak T, Nguyen KT, Schmid MJ et al (2005). Surgical and pharmacological suppression of glucocorticoids prevents the enhancement of morphine conditioned place preference by uncontrollable stress in rats. Psychopharmacology (Berl) 179: 409-417.
10. Dietz D, Wang H, Kabbaj M (2007). Corticosterone fails to produce conditioned place preference or conditioned place aversion in rats. Behav Brain Res 181: 287-291. (Pubitemid 46898656)
11. Dinieri JA, Nemeth CL, Parsegian A, Carle T, Gurevich VV, Gurevich E et al (2009). Altered sensitivity to rewarding and aversive drugs in mice with inducible disruption of cAMP response element-binding protein function within the nucleus accumbens. J Neurosci 29: 1855-1859.
12. Duncan GE, Inada K, Farrington JS, Koller BH, Moy SS (2009). Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stress. Brain Res 1265: 186-195.
13. Duncan GE, Johnson KB, Breese GR (1993). Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunor-eactivity. J Neurosci 13: 3932-3943.
14. Ebner K, Wotjak CT, Holsboer F, Landgraf R, Engelmann M (1999). Vasopressin released within the septal brain area during swim stress modulates the behavioural stress response in rats. Eur J Neurosci 11: 997-1002.
15. Faure A, Reynolds SM, Richard JM, Berridge KC (2008). Mesolimbic dopamine in desire and dread: enabling motivation to be generated by localized glutamate disruptions in nucleus accumbens. J Neurosci 28: 7184-7192.
16. Franklin KBJ, Paxinos G (2007). The Mouse Brain in Stereotaxic Coordinates. 3rd edn. Academic Press: San Diego.
17. Franklin TR, Druhan JP (2000). Expression of Fos-related antigens in the nucleus accumbens and associated regions following exposure to a cocaine-paired environment. Eur J Neurosci 12: 2097-2106.
18. Goeders NE (1997). A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 22: 237-259.
19. Goeders NE, Bienvenu OJ, De Souza EB (1990). Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat brain. Brain Res 531: 322-328.
20. Goeders NE, Guerin GF (1994). Non-contingent electric footshock facilitates the acquisition of intravenous cocaine self-administration in rats. Psychopharmacology (Berl) 114: 63-70.
21. Goeders NE, Guerin GF (2000). Effects of the CRH receptor antagonist CP-154, 526 on intravenous cocaine self-administration in rats. Neuropsychopharmacology 23: 577-586.
22. Griebel G, Simiand J, Steinberg R, Jung M, Gully D, Roger P et al (2002). 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4- methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders. J Pharmacol Exp Ther 301: 333-345. (Pubitemid 34250312)
23. Hadaway PF, Alexander BK, Coambs RB, Beyerstein B (1979). The effect of housing and gender on preference for morphine-sucrose solutions in rats. Psychopharmacology (Berl) 66: 87-91.
24. Haney M, Maccari S, Le Moal M, Simon H, Piazza PV (1995). Social stress increases the acquisition of cocaine self-administration in male and female rats. Brain Res 698: 46-52.
25. Jutkiewicz EM, Wood SK, Houshyar H, Hsin LW, Rice KC, Woods JH (2005). The effects of CRF antagonists, antalarmin, CP154 526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats. Psychopharmacology 180: 215-223.
26. Kaplan HB, Martin SS, Johnson RJ, Robbins CA (1986). Escalation of marijuana use: application of a general theory of deviant behavior. J Health Soc Behav 27: 44-61.
27. Kasagi Y, Horiba N, Sakai K, Fukuda Y, Suda T (2002). Involvement of cAMP-response element binding protein in corticotropin-releasing factor (CRF)-induced down-regulation of CRF receptor 1 gene expression in rat anterior pituitary cells. J Neuroendocrinol 14: 587-592.
28. Kelley AE (2004). Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev 27: 765-776.
29. Kheirbek MA, Beeler JA, Ishikawa Y, Zhuang X (2008). A cAMP pathway underlying reward prediction in associative learning. J Neurosci 28: 11401-11408.
30. Kirby LG, Lucki I (1997). Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytrypta-mine and 5-hydroxyindoleacetic acid in the rat. J Pharmacol Exp Ther 282: 967-976.
31. Koob G, Kreek MJ (2007). Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164: 1149-1159.
32. Kreibich AS, Blendy JA (2004). cAMP response element-binding protein is required for stress but not cocaine-induced reinstatement. J Neurosci 24: 6686-6692.
33. Kwon MS, Seo YJ, Shim EJ, Choi SS, Lee JY, Suh HW (2006). The effect of single or repeated restraint stress on several signal molecules in paraventricular nucleus, arcuate nucleus and locus coeruleus. Neuroscience 142: 1281-1292.
34. Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008). The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28: 407-414.
35. Li Y, Li GY, Li LJ, Wang CH, Li ZX, Zhang JL et al (2007). Subsequently enhanced CPP to morphine following chronic but not acute footshock stress associated with corticosterone mechanism in rats. Int J Neurosci 117: 1237-1255.
36. Liu J, Yu B, Orozco-Cabal L, Grigoriadis DE, Rivier J, Vale WW et al (2005). Chronic cocaine administration switches cortico-tropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum. J Neurosci 25: 577-583.
37. Louilot A, Taghzouti K, Simon H, Le Moal M (1989). Limbic system, basal ganglia, and dopaminergic neurons. Executive and regulatory neurons and their role in the organization of behavior. Brain Behav Evol 33: 157-161.
38. Lu L, Liu Z, Huang M, Zhang Z (2003). Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. J Neurochem 84: 1378-1386.
39. Maddahian E, Newcomb MD, Bentler PM (1988a). Adolescent drug use and intention to use drugs: concurrent and longitudinal analyses of four ethnic groups. Addict Behav 13: 191-195.
40. Maddahian E, Newcomb MD, Bentler PM (1988b). Risk factors for substance use: ethnic differences among adolescents. J Subst Abuse 1: 11-23.
41. McEvoy AN, Bresnihan B, Fitzgerald O, Murphy EP (2002). Corticotropin-releasing hormone signaling in synovial tissue vascular endothelium is mediated through the cAMP/CREB pathway. Ann N Y Acad Sci 966: 119-130.
42. McFall ME, Mackay PW, Donovan DM (1992). Combat-related posttraumatic stress disorder and severity of substance abuse in Vietnam veterans. J Stud Alcohol 53: 357-363.
43. McLaughlin JP, Marton-Popovici M, Chavkin C (2003). Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23: 5674-5683.
44. Miczek KA, Mutschler NH (1996). Activational effects of social stress on IV cocaine self-administration in rats. Psychopharma-cology (Berl) 128: 256-264.
45. Piazza PV, Deminiere JM, le Moal M, Simon H (1990). Stress-and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res 514: 22-26.
46. Piazza PV, Le Moal M (1998). The role of stress in drug self-administration. Trends Pharmacol Sci 19: 67-74.
47. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon Jr WA (2001). Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci 21: 7397-7403.
48. Ramsey NF, Van Ree JM (1993). Emotional but not physical stress enhances intravenous cocaine self-administration in drug-naive rats. Brain Res 608: 216-222.
49. Reynolds SM, Berridge KC (2002). Positive and negative motivation in nucleus accumbens shell: bivalent rostrocaudal gradients for GABA-elicited eating, taste 'liking'/'disliking' reactions, place preference/avoidance, and fear. J Neurosci 22: 7308-7320.
50. Sarnyai Z, Shaham Y, Heinrichs SC (2001). The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 53: 209-243.
51. Shaham Y, Kelsey JE, Stewart J (1995). Temporal factors in the effect of restraint stress on morphine-induced behavioral sensitization in the rat. Psychopharmacology (Berl) 117: 102-109.
52. Shaham Y, Rodaros D, Stewart J (1994a). Reinstatement of heroin-reinforced behavior following long-term extinction: implications for the treatment of relapse to drug taking. Behav Pharmacol 5: 360-364.
53. Shaham Y, Stewart J (1994b). Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats. Psychopharmacology (Berl) 114: 523-527.
54. Sheehan TP, Chambers RA, Russell DS (2004). Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Res Brain Res Rev 46: 71-117.
55. Sinha R (2007). The role of stress in addiction relapse. Curr Psychiatry Rep 9: 388-395.
56. Trinh JV, Nehrenberg DL, Jacobsen JP, Caron MG, Wetsel WC (2003). Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice. Neuroscience 118: 297-310.
57. Valverde O, Mantamadiotis T, Torrecilla M, Ugedo L, Pineda J, Bleckmann S et al (2004). Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice. Neuropsy-chopharmacology 29: 1122-1133.
58. Walters CL, Blendy JA (2001). Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. J Neurosci 21: 9438-9444.
59. Walters CL, Cleck JN, Kuo YC, Blendy JA (2005). Mu-opioid receptor and CREB activation are required for nicotine reward. Neuron 46: 933-943.
60. Webster EL, Lewis DB, Torpy DJ, Zachman EK, Rice KC, Chrousos GP (1996). In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137: 5747-5750.